{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:17:25Z","timestamp":1762543045721},"reference-count":3,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamaophthalmol.2019.1427","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T11:03:16Z","timestamp":1558004596000},"page":"853","source":"Crossref","is-referenced-by-count":7,"title":["Association of Choroidal Effusion and Infusion of Daratumumab"],"prefix":"10.1001","volume":"137","author":[{"given":"Peter K.","family":"Rasmussen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Rigshospitalet Glostrup, University Hospital Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens F.","family":"Kiilgaard","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rigshospitalet Glostrup, University Hospital Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Salomo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rigshospitalet, University Hospital Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"14","key":"elo190007r1","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1607751","article-title":"Daratumumab, lenalidomide, and dexamethasone for multiple myeloma.","volume":"375","author":"Dimopoulos","year":"2016","journal-title":"N Engl J Med"},{"key":"elo190007r2","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3389\/fimmu.2018.01228","article-title":"Daratumumab for the treatment of multiple myeloma.","volume":"9","author":"Plesner","year":"2018","journal-title":"Front Immunol"},{"key":"elo190007r3","article-title":"Ocular adverse events associated with MEK inhibitors","author":"M\u00e9ndez-Mart\u00ednez","journal-title":"Retina"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaophthalmology\/article-pdf\/137\/7\/853\/17716801\/jamaophthalmology_rasmussen_2019_lo_190007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T11:01:38Z","timestamp":1562842898000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2019.1427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":3,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.1427","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}